Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-27

Clinical Trial Update: Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update targeting beta-cell failure in lean patients with type 2 diabetes has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Leeds | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED